Filing Details

Accession Number:
0001209191-18-061656
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-07 19:23:56
Reporting Period:
2018-12-06
Accepted Time:
2018-12-07 19:23:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286710 Francis Cano C/o Dynavax Technologies Corporation
2929 Seventh Street, Suite 100
Berkeley CA 94710
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-06 2,000 $10.47 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold at prices ranging from $10.47 to $10.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.